A Phase 1/Randomized Phase 2 Study of M3814 (peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Sarah Davis

Sarah Davis

Study ID

Protocol Number: 20-2093

More information available at ClinicalTrials.gov: NCT04172532

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers